Mesenchymal cell proliferation and programmed cell death: key players in fibrogenesis and new targets for therapeutic intervention

Blocking Angiotensin II Type 1 Receptor Triggers Apoptotic Cell Death in Human Pancreatic Cancer Cells

(2010) Qiaoke Gong et al.   PANCREAS

Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis

(2009) J. P. GISBERT et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Synergistic antifibrotic efficacy of statin and protein kinase C inhibitor in hepatic fibrosis

(2009) Jong In Yang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohnʼs disease

(2009) Jean-Marc Sabate et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Angiotensin II Activates IκB Kinase Phosphorylation of RelA at Ser536 to Promote Myofibroblast Survival and Liver Fibrosis

(2009) Fiona Oakley et al.   GASTROENTEROLOGY

Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans

(2009) Montserrat Moreno et al.   HEPATOLOGY

NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation

(2009) Rachel Cooney et al.   NATURE MEDICINE

Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab

(2008) Hiroki Mitoma et al.   ARTHRITIS AND RHEUMATISM

NF-κB is a critical regulator of the survival of rodent and human hepatic myofibroblasts

(2008) Martha R. Watson et al.   JOURNAL OF HEPATOLOGY

The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection

(2007) Hermann E. Wasmuth et al.   JOURNAL OF HEPATOLOGY